Evidence map›Paper›PMID 32679543›Full record

ArticleMolecular therapy. Nucleic acids2020

lncRNA STEAP3-AS1 Modulates Cell Cycle Progression via Affecting CDKN1C Expression through STEAP3 in Colon Cancer.

Heya Na, Xiaomeng Li, Xinsheng Zhang, Yue Xu, Yuzhu Sun, Jingyi Cui, Zihao Chen, Xiaomeng Shi, Shuangyi Ren, Yunfei Zuo

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy. Nucleic acids, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. The Role of Iron in Cancer Progression.Frontiers in oncology · 2021
    Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Heya NaDepartment of Clinical Biochemistry, Dalian Medical University, Dalian 116044, China; Department of Laboratory Medicine, The People's Hospital of Liaoning Province, Shenyang 110016, China.
Xiaomeng LiDepartment of Clinical Biochemistry, Dalian Medical University, Dalian 116044, China.
Xinsheng ZhangDepartment of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.
Yue XuDepartment of Clinical Biochemistry, Dalian Medical University, Dalian 116044, China.
Yuzhu SunDepartment of Clinical Biochemistry, Dalian Medical University, Dalian 116044, China.
Jingyi CuiDepartment of Clinical Biochemistry, Dalian Medical University, Dalian 116044, China.
Zihao ChenDepartment of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.
Xiaomeng ShiDepartment of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China.
Shuangyi RenDepartment of General Surgery, The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, China. Electronic address: rsydl@aliyun.com.
Yunfei ZuoDepartment of Clinical Biochemistry, Dalian Medical University, Dalian 116044, China. Electronic address: zyf04112002@aliyun.com.
Dalian Medical University · CNSecond Affiliated Hospital of Dalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies have reported that long noncoding RNAs (lncRNAs) have acted as new players during tumorigenesis. Metallothionein also plays an important role in tumor progression. It is mainly considered to be involved in the process of cell proliferation, oxidative stress, and multidrug resistance. However, the potential involvement of metallothionein-related lncRNAs in colon cancer remains poorly understood. In our study, we found that MT1M affected the expression of lncRNA STEAP3-AS1. STEAP3-AS1 is located in physical contiguity with STEAP3 and notably increased in colon cancer tissues and cell lines. STEAP3-AS1 expression was negatively associated with the expression of STEAP3. High levels of STEPA3-AS1 were associated with poor overall survival in colon cancer patients. In in vitro assays, STEAP3-AS1 knockdown could inhibit colon cancer cell proliferation and migration and arrest colon cancer cells at the G

Indexed as

CDKN1Ccolon cancermetallothioneinSTEAP3STEAP3-AS1

Identifiers

PMID32679543
PMCPMC7360886
OpenAlexW3036741649

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.